Summary
We have analysed DNA extracted from the serum and peritoneal fluid of 20 ovarian cancer patients for the presence of tumour-specific genetic alterations. The 20 patients included six with stage Ia disease. Using six polymorphic microsatellite loci we were able to detect novel alleles or loss of heterozygosity in 17/20 serum samples and 12/19 peritoneal fluid samples. Tumour-specific abnormalities were detected in the serum of all but one of the stage Ia cases. Half of the occurrences of loss of heterozygosity identified in primary tumour material were detectable in the serum samples. Novel alleles indicative of microsatellite instability were found in 3/6 patients with stage Ia disease but in only 1/14 of patients with more advanced disease. One of the eight patients in the control group displayed abnormalities in her serum DNA. The ease with which tumour-specific alterations were detected in serum and peritoneal samples from ovarian cancer patients, using a panel of only six polymorphic microsatellite markers on four chromosomes, suggests that molecular detection methods could prove useful in the staging, monitoring and screening of this disease.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berek, J. S. (1994). Epithelial ovarian cancer. In Practical Gynaecological Oncology, 2nd edn, Berek JS, Hacker NF (eds), pp. 327–375. Williams and Wilkins: Baltimore
Bicknell, D. C., Kaklamanis, L., Hampson, R., Bodmer, W. F. & Karran, P. (1996). Selection for beta 2-microglobulin mutation in mismatch repair-defective colorectal carcinomas. Curr Biol 6: 1695–1697.
Caldas, C. (1997). Molecular staging of cancer: is it time? Lancet 350: 231
Cawkwell, L., Lewis, F. A. & Quirke, P. (1994). Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction. Br J Cancer 70: 813–818.
Chen, X. Q., Stroun, M., Magnenat, J. L., Nicod, L. P., Kurt, A. M., Lyautey, J., Lederrey, C. & Anker, P. (1996). Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2: 1033–1035.
Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Halling, K. C., Keeney, G., Podratz, K. C. & Jenkins, R. B. (1993). Human epithelial ovarian cancer allelotype. Cancer Res 53: 2393–2398.
Droegemueller, W. (1994). Screening for ovarian carcinoma: hopeful and wishful thinking. Am J Obstet Gynecol 170: 1095–1098.
Fujita, M., Enomoto, T., Yoshino, K., Nomura, T., Buzard, G. S., Inoue, M. & Okudaira, Y. (1995). Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Int J Cancer 64: 361–366.
Gallion, H. H., Pieretti, M., DePriest, P. D. & van Nagell, J. R. (1995). The molecular basis of ovarian cancer. Cancer 76: 1992–1997.
Gao, X., Zacharek, A., Salkowski, A., Grignon, D. J., Sakr, W., Porter, A. T. & Honn, K. V. (1995). Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. Cancer Res 55: 1002–1005.
Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M. & Weissenbach, J. (1994). The 1993–94 Genethon human genetic linkage map. Nat Genet 7: 246–339.
Hibi, K., Robinson, C. R., Booker, S., Wu, L., Hamilton, S. R., Sidransky, D. & Jen, J. (1998). Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58: 1405–1407.
King, B. L., Carcangiu, M. L., Carter, D., Kiechle, M., Pfisterer, J., Pfleiderer, A. & Kacinski, B. M. (1995). Microsatellite instability in ovarian neoplasms. Br J Cancer 72: 376–382.
Lothe, R. A., Peltomaki, P., Meling, G. I., Aaltonen, L. A., Nystrom-Lahti, M., Pylkkanen, L., Heimdal, K., Andersen, T. I., Moller, P. & Rognum, T. O. et al (1993). Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 53: 5849–5852.
Lukish, J. R., Muro, K., DeNobile, J., Katz, R., Williams, J., Cruess, D. F., Drucker, W., Kirsch, I. & Hamilton, S. R. (1998). Prognostic significance of DNA replication errors in young patients with colorectal cancer. Ann Surg 227: 51–56.
Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M. & Sidransky, D. (1994). Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 54: 1634–1637.
Mao, L., Schoenberg, M. P., Scicchitano, M., Erozan, Y. S., Merlo, A., Schwab, D. & Sidransky, D. (1996). Molecular detection of primary bladder cancer by microsatellite analysis. Science 271: 659–662.
Nawroz, H., Koch, W., Anker, P., Stroun, M. & Sidransky, D. (1996). Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2: 1035–1037.
Osborne, R. J. & Leech, V. (1994). Polymerase chain reaction allelotyping of human ovarian cancer. Br J Cancer 69: 429–438.
Phillips, N., Ziegler, M., Saha, B. & Xynos, F. (1993). Allelic loss on chromosome 17 in human ovarian cancer. Int J Cancer 54: 85–91.
Schultz, D. C., Vanderveer, L., Buetow, K. H., Boente, M. P., Ozols, R. F., Hamilton, T. C. & Godwin, A. K. (1995). Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res 55: 2150–2157.
Sidransky, D., Tokino, T., Hamilton, S. R., Kinzler, K. W., Levin, B., Frost, P. & Vogelstein, B. (1992). Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors. Science 256: 102–105.
Skates, S. J., Xu, F. J., Yu, Y. H., Sjovall, K., Einhorn, N., Chang, Y. C., Bast, R. C. & Knapp, R. C. (1995). Toward an optimal algorithm for ovarian-cancer screening with longitudinal tumor-markers. Cancer 76: 2004–2010.
Smith, B., Selby, P., Southgate, J., Pittman, K., Bradley, C. & Blair, G. E. (1991). Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 338: 1227–1229.
Sood, A. K. & Buller, R. E. (1996). Genomic instability in ovarian cancer: a reassessment using an arbitrarily primed polymerase chain reaction. Oncogene 13: 2499–2504.
Spirio, L., Nelson, L., Ward, K., Burt, R., White, R. & Leppert, M. (1993). A CA-repeat polymorphism close to the adenomatous polyposis coli (APC) gene offers improved diagnostic testing for familial APC. Am J Hum Genet 52: 286–296.
van Nagell, J. R. Jr, Gallion, H. H., Pavlik, E. J. & DePriest, P. D. (1995). Ovarian cancer screening. Cancer 76: 2086–2091.
Woolas, R. P., Xu, F. J., Jacobs, I. J., Yu, Y. H., Daly, L., Berchuck, A., Soper, J. T., Clarke-Pearson, D. L., Oram, D. H. & Bast, R. C. (1993). Elevation of multiple serum markers in patients with stage I ovarian cancer. J Natl Cancer Inst 85: 1748–1751.
Zenklusen, J. C., Weitzel, J. N., Ball, H. G. & Conti, C. J. (1995). Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor-suppressor gene. Oncogene 11: 359–363.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Hickey, K., Boyle, K., Jepps, H. et al. Molecular detection of tumour DNA in serum and peritoneal fluid from ovarian cancer patients. Br J Cancer 80, 1803–1808 (1999). https://doi.org/10.1038/sj.bjc.6690601
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690601
Keywords
This article is cited by
-
The prognostic impact of peritoneal tumour DNA in gastrointestinal and gynaecological malignancies: a systematic review
British Journal of Cancer (2023)
-
Role of Circulating Cell-Free DNA in Cancers
Molecular Diagnosis & Therapy (2015)